Australia's FIRB grants approval for Sirtex's Chinese buyout
Note: This section contains information in English only.
Tue, 03 Jul 2018 12:39:49 GMT
Source: Dukascopy Bank SA
Sirtex Medical, the liver cancer treatment producer, has been granted an approval by the Australian Foreign Investment Review Board doe its $1.4B buyout by the Chinese consortium.
For further information regarding potential cooperation, please call us or make callback request.
To learn more about Dukascopy Bank Binary Options
/ Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Business Introducer and other trading related information, please call us or make callback request.
For further information regarding potential cooperation, please call us or make callback request.